The document describes a new method called the mutagenic chain reaction (MCR) that uses the CRISPR/Cas9 system to efficiently generate homozygous loss-of-function mutations from an initial heterozygous mutation. The researchers developed an MCR construct containing Cas9, a guide RNA targeting a genomic sequence of interest, and flanking homology arms. This construct inserts into the target site and expresses Cas9 and guide RNA to cleave the opposite chromosome, converting it to homozygosity via homology-directed repair. Testing this method in Drosophila, they found it efficiently spread mutations from the initial chromosome to the homologous one in somatic and germline cells, demonstrating the potential of MCR for